Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease
Alzheimer’s disease (AD) is the most common cause of dementia. However, current diagnostic tools are subjective, cost-inefficient, and difficult to administer. Blood-based biomarkers, which are quantitative and non-invasive, have thus been increasingly investigated as potential diagnostic tools. Exp...
Saved in:
主要作者: | Dan Yuet Ruh |
---|---|
其他作者: | - |
格式: | Final Year Project |
語言: | English |
出版: |
Nanyang Technological University
2024
|
主題: | |
在線閱讀: | https://hdl.handle.net/10356/176360 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
相似書籍
-
Discovery of plasma biomarkers related to blood-brain barrier dysregulation in Alzheimer's disease
由: Dan, Yuet Ruh, et al.
出版: (2025) -
Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer's disease
由: Phang, Sean Kia Ann, et al.
出版: (2025) -
Encoding and decoding multimodal brain images for disease biomarker discovery
由: Chan, Yi Hao
出版: (2024) -
Current and future trends in biomarkers for the early detection of Alzheimer's disease in Asia: expert opinion
由: Kandiah, Nagaendran, et al.
出版: (2024) -
Brain macrophages in Alzheimer's disease: from ontogeny to function
由: Wu, Xiaoting
出版: (2024)